tradingkey.logo
搜索

Atea Pharmaceuticals Inc

AVIR
添加自选
4.810USD
+0.080+1.69%
收盘 07-27 16:00美东报价延迟15分钟
384.93M总市值
亏损市盈率 TTM

AVIR 财务数据

通过专为投资者打造的一站式数据看板,全面查看 Atea Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。

Atea Pharmaceuticals Inc财报日历

最新发布
5月 12, 2026
每股收益 / 预测值
-0.57/-0.59
营业收入 / 预测值
--/0.00
报告期
FY2025 财报
营业收入(YoY)
--
--
每股收益(YoY)
-1.94
2.76%
分析师评级
BUY
2026/07/27
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
财务指标
每股收益
-42.56%-0.57
-44.64%-0.57
-44.15%-0.53
7.74%-0.44
46.54%-0.40
15.39%-0.40
7.15%-0.37
-42.32%-0.48
-76.87%-0.75
-13.54%-0.47
---0.40
---0.34
---0.43
---0.41
---0.98
----
----
----
----
----
营业收入
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
295.16%192.18M
--32.81M
--60.39M
净利润
-32.59%-45.44M
-33.76%-44.87M
-34.98%-42.05M
8.29%-37.16M
45.75%-34.27M
14.35%-33.54M
6.01%-31.15M
-43.78%-40.52M
-78.11%-63.17M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-129.40%-34.43M
71.39%-8.07M
-2136.06%-31.34M
-237.00%-42.08M
467.06%117.13M
-59.99%-28.19M
115.40%1.54M
资产负债率
----
----
----
----
----
----
----
--0.00%
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
营业收入
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
295.16%192.18M
--32.81M
--60.39M
营业利润
-26.98%-48.01M
-55.14%-54.71M
-46.79%-45.45M
-16.92%-41.42M
-23.74%-37.81M
-24.40%-35.27M
-0.99%-30.97M
-20.89%-35.43M
6.33%-30.55M
-4.70%-28.35M
-15.60%-30.66M
-2.26%-29.31M
-13.09%-32.62M
-119.45%-27.08M
-516.52%-26.52M
-176.37%-28.66M
-159.15%-28.84M
363.90%139.22M
167.48%6.37M
906.88%37.53M
净利润
-32.59%-45.44M
-33.76%-44.87M
-34.98%-42.05M
8.29%-37.16M
45.75%-34.27M
14.35%-33.54M
6.01%-31.15M
-43.78%-40.52M
-78.11%-63.17M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-129.40%-34.43M
71.39%-8.07M
-2136.06%-31.34M
-237.00%-42.08M
467.06%117.13M
-59.99%-28.19M
115.40%1.54M
流动资产
-39.31%263.20M
-32.74%310.99M
-30.96%336.14M
-23.85%385.60M
-20.97%433.71M
-21.70%462.36M
-19.30%486.91M
-18.44%506.37M
-13.22%548.76M
-10.66%590.46M
-11.53%603.32M
-9.95%620.83M
-11.33%632.39M
-14.43%660.92M
-19.10%681.93M
-20.85%689.45M
-15.11%713.23M
-10.55%772.40M
677.53%842.95M
635.42%871.11M
流动负债总额
53.43%33.37M
113.86%39.78M
-19.91%20.18M
-24.42%20.12M
-47.36%21.75M
-42.54%18.60M
33.33%25.19M
64.73%26.62M
234.20%41.31M
75.21%32.38M
20.85%18.89M
-35.64%16.16M
-56.79%12.36M
-67.52%18.48M
-94.03%15.63M
-90.83%25.11M
-88.75%28.61M
-81.99%56.88M
2322.82%262.05M
3777.20%273.65M
总资产
-39.30%267.08M
-32.16%315.22M
-30.14%342.96M
-23.27%391.61M
-20.44%439.96M
-21.90%464.67M
-19.26%490.96M
-18.47%510.38M
-13.34%553.03M
-10.76%594.97M
-11.43%608.08M
-9.84%626.03M
-11.02%638.13M
-13.74%666.71M
-18.60%686.58M
-20.33%694.34M
-14.69%717.19M
-10.51%772.89M
666.08%843.50M
627.83%871.54M
总负债
15.54%33.37M
54.20%39.78M
-16.19%27.18M
-19.83%27.19M
-40.65%28.88M
-35.13%25.80M
23.12%32.44M
43.22%33.91M
143.91%48.66M
52.19%39.78M
12.64%26.34M
-30.11%23.68M
-46.52%19.95M
-58.39%26.14M
-91.07%23.39M
-87.62%33.88M
-85.34%37.30M
-80.11%62.81M
2310.34%262.05M
3740.07%273.68M
总权益
-43.15%233.71M
-37.24%275.43M
-31.13%315.78M
-23.52%364.42M
-18.50%411.08M
-20.95%438.87M
-21.18%458.52M
-20.90%476.47M
-18.41%504.37M
-13.33%555.19M
-12.28%581.73M
-8.80%602.35M
-9.08%618.18M
-9.79%640.57M
14.06%663.19M
10.47%660.46M
15.97%679.88M
29.62%710.08M
485.94%581.45M
430.88%597.86M
经营净额
-51.79%-46.39M
7.15%-28.22M
-75.28%-40.38M
22.11%-32.87M
23.33%-30.56M
-39.22%-30.40M
-30.95%-23.04M
-161.80%-42.20M
-33.55%-39.87M
-1.34%-21.83M
17.19%-17.59M
15.98%-16.12M
49.41%-29.85M
71.43%-21.55M
-193.98%-21.24M
-10.59%-19.19M
-250.47%-59.01M
-123.68%-75.42M
338.40%22.60M
-122.47%-17.35M
投资净额
-65.26%29.74M
1482.55%46.59M
133.85%41.30M
-87.74%15.29M
50.71%85.61M
-112.13%-3.37M
-108.52%-122.01M
167.77%124.69M
132.03%56.80M
-17.07%27.77M
87.98%-58.51M
2578.18%46.56M
55736.36%24.48M
837300.00%33.49M
---486.98M
---1.88M
---44.00K
20.00%-4.00K
100.00%0.00
100.00%0.00
融资净额
174.06%257.00K
--0.00
-9762.39%-11.30M
---14.09M
-331.33%-347.00K
--0.00
27.17%117.00K
--0.00
-9.09%150.00K
--0.00
-37.41%92.00K
--0.00
-26.01%165.00K
-100.00%0.00
-81.51%147.00K
-100.00%0.00
-52.65%223.00K
-99.97%142.00K
187.08%795.00K
-99.95%57.00K

常见问题

Atea Pharmaceuticals Inc的流动资产是多少?

根据Atea Pharmaceuticals Inc的FY2025财报,流动资产为310.99M(同比变化-32.74)。

Atea Pharmaceuticals Inc的总资产是多少?

根据Atea Pharmaceuticals Inc的FY2025财报,Atea Pharmaceuticals Inc的总资产为315.22M(同比变化-32.16)。

Atea Pharmaceuticals Inc的总负债是多少?

根据Atea Pharmaceuticals Inc的FY2025财报,Atea Pharmaceuticals Inc的总负债为39.78M(同比变化54.20)。

Atea Pharmaceuticals Inc的总权益是多少?

根据Atea Pharmaceuticals Inc的FY2025财报,Atea Pharmaceuticals Inc的总权益为275.43M(同比变化-37.24)。

Atea Pharmaceuticals Inc的净营业收入是多少?

根据Atea Pharmaceuticals Inc的FY2025财报,Atea Pharmaceuticals Inc的净营业收入为-179.40M(同比变化-35.68)。

Atea Pharmaceuticals Inc的净投资是多少?

根据Atea Pharmaceuticals Inc的FY2025财报,Atea Pharmaceuticals Inc的净投资为188.79M(同比变化236.50)。

Atea Pharmaceuticals Inc的净融资是多少?

根据Atea Pharmaceuticals Inc的FY2025财报,Atea Pharmaceuticals Inc的净融资为-25.75M(同比变化-9742.32)。

Atea Pharmaceuticals Inc的每股收益(EPS)是多少?

根据Atea Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为-1.94(同比变化2.76)。

Atea Pharmaceuticals Inc的净利润是多少?

根据Atea Pharmaceuticals Inc的FY2025财报,净利润为-158.35M(同比变化5.96)。

Atea Pharmaceuticals Inc的股东权益回报率(ROE)是多少?

根据Atea Pharmaceuticals Inc的FY2025财报,股东权益回报率(ROE)为-44.34(同比变化-30.87)。

Atea Pharmaceuticals Inc的资产回报率(ROA)是多少?

根据Atea Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为-40.61(同比变化-27.77)。

Atea Pharmaceuticals Inc的营业利润是多少?

根据Atea Pharmaceuticals Inc的FY2025财报,营业利润为-179.40M(同比变化-35.68)。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有